Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Segments and Revenue Breakdown
IDXX logo

IDEXX Hits $1.1 Billion Net Income Driven by 79% Recurring Revenue

IDXX10-KFiling Date: 2/20/2026
IDEXX Laboratories, Inc.
Description

What this story covers

IDEXX Laboratories demonstrated financial resilience in 2025, leveraging AI-powered diagnostic innovations and a 79% recurring revenue model to achieve $1.1 billion in net income, successfully offsetting a 2% decline in U.S. veterinary clinical visits.

Story snapshot

CompanyIDEXX Laboratories, Inc.
TickerIDXX
VariantStandard detailed
Duration11:14
Filing type10-K
PeriodAnnual 2025
IndustryHealthcare & Pharmaceuticals
Accession0000874716-26-000038
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in